Laparoscopic Pyelolithotomy Versus Percutaneous Nephrolothotomy for Management of >3cm Renal Pelvis Stone
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01637337 |
Recruitment Status
:
Completed
First Posted
: July 11, 2012
Last Update Posted
: April 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Renal Pelvis Stone >3cm | Procedure: laparoscopic pyelolithotomy Procedure: percutaneous nephrolithotomy | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Study Start Date : | May 2012 |
Actual Primary Completion Date : | December 2012 |
Actual Study Completion Date : | January 2013 |
Arm | Intervention/treatment |
---|---|
Active Comparator: laparoscopic pyelolithotomy |
Procedure: laparoscopic pyelolithotomy
laparoscopy
|
Sham Comparator: percutaneous nephrolithotomy |
Procedure: percutaneous nephrolithotomy
percutaneous nephrolithotomy
|
- Stone free rate [ Time Frame: at least 6 month after surgery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults with >3cm renal pelvis stone
Exclusion Criteria:
- History of previous surgery on the target kidney
- Active UTI
- Coagulopathy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01637337
Iran, Islamic Republic of | |
Shiraz University of Medical Sciences | |
Shiraz, Fars, Iran, Islamic Republic of, 71344 |
Responsible Party: | Alireza Aminsharifi, Assistant Professor of Urology, Shiraz University of Medical Sciences |
ClinicalTrials.gov Identifier: | NCT01637337 History of Changes |
Other Study ID Numbers: |
89-01-01-2391 |
First Posted: | July 11, 2012 Key Record Dates |
Last Update Posted: | April 20, 2016 |
Last Verified: | April 2016 |